Frontiers in Cardiovascular Medicine

MARCH 3, 2025

IntroductionSystemic inflammation is recognised as a critical driver of atherosclerotic cardiovascular disease (ASCVD), especially in patients with comorbid chronic kidney disease (CKD).

Kidney Disease 52

Kidney Disease Cardiovascular Disease Cholesterol Obesity 52

Frontiers in Cardiovascular Medicine

OCTOBER 9, 2024

Additionally, restricted cubic splines (RCS) analysis was also employed.ResultsWe found that those with AAC were significantly older and had a higher prevalence of smoking and chronic kidney disease (CKD) prevalence compared to those without AAC.

Aortic 52

Aortic Obesity Kidney Disease Public Health 52

Cardiometabolic Health Congress

JULY 25, 2023

Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

These new guidelines provide necessary updates to both the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation and the 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111